The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
Open accessAbstract
Purpose: To present comprehensive examinations of the assumptions made in functional diffusion map (fDM) analyses and provide a biological basis for fDM classification. Materials and Methods: Sixty‐nine patients with gliomas were enrolled in this study. To determine the sensitivity of apparent diffusion coefficients (ADCs) to cellularity, cell density from stereotactic biopsy specimens was correlated with preoperative ADC maps. For definition of ADC thresholds used for fDMs, the 95% confidence intervals (CI) for changes in voxel‐wise ADC measurements in normal appearing tissue was analyzed. The sensitivity and specificity to progressing disease was examined using both radiographic and neurological criteria. Results: Results support the hypothesis that ADC is inversely proportional to cell density with a sensitivity of 1.01 × 10−7 [mm 2/s]/[nuclei/mm 2]. The 95% CI for white matter = 0.25 × 10−3 mm 2/s, gray matter = 0.31 × 10−3 mm 2/s, a mixture of white and gray matter = 0.40 × 10−3 mm 2/s, and a mixture of white matter, gray matter, and cerebrospinal fluid = 0.75 × 10−3 mm 2/s. Application of these measurements as ADC thresholds produce varying levels of sensitivity and specificity to disease progression, which were all significantly better than chance. Conclusion: This study suggests fDMs are valid biomarkers for brain tumor cellularity. J. Magn. Reson. Imaging 2010;31:538–548. ©2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Padhani, A. R., Liu, G., Mu-Koh, D., Chenevert, T. L., Thoeny, H. C., Takahara, T., Dzik-Jurasz, A., Ross, B. D., Van Cauteren, M., Collins, D., et al. (2009) · Neoplasia · doi:10.1593/neo.81328 · Cited by 1,989
Mathematical Biology: I. An Introduction
(2002) · Interdisciplinary Applied Mathematics · doi:10.1007/b98868 · Cited by 1,763
Sugahara, T., Korogi, Y., Kochi, M., Ikushima, I., Shigematu, Y., Hirai, T., Okuda, T., Liang, L., Ge, Y., Komohara, Y., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199901)9:1<53::aid-jmri7>3.0.co;2-2 · Cited by 1,163
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067
The role of diffusion-weighted imaging in patients with brain tumors.
Kono, K., Inoue, Y., Nakayama, K., Shakudo, M., Morino, M., Ohata, K., Wakasa, K., & Yamada, R. (2001) · PubMed Central · Cited by 686
Chenevert, T. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2029 · Cited by 673
Real-time 3D image registration for functional MRI
Cox, R. W., & Jesmanowicz, A. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199912)42:6<1014::aid-mrm4>3.0.co;2-f · Cited by 663
Moffat, B. A., Chenevert, T. L., Lawrence, T. S., Meyer, C. R., Johnson, T. D., Dong, Q., Tsien, C., Mukherji, S., Quint, D. J., Gebarski, S. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501532102 · Cited by 643
Cited by
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
(2015) · Neuro-Oncology · doi:10.1093/neuonc/nov095 · Cited by 663
Surov, A., Meyer, H. J., & Wienke, A. (2017) · Oncotarget · doi:10.18632/oncotarget.17752 · Cited by 317
Pseudoprogression of brain tumors
Thust, S. C., van den Bent, M. J., & Smits, M. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26171 · Cited by 304
Ellingson, B. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0506-0 · Cited by 132
Self-citationMagnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy
Lawrence, L. S. P., Maralani, P. J., Das, S., Sahgal, A., Stanisz, G. J., & Lau, A. Z. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04856-3 · Cited by 4
Metadata
- Authors
- Ellingson, B. M., Malkin, M. G., Rand, S. D., Connelly, J. M., Quinsey, C., LaViolette, P. S., Bedekar, D. P., & Schmainda, K. M.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2010-02-25
- Volume
- 31
- Issue
- 3
- Pages
- 538-548
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2140844379
- Cited by
- 277
- References
- 26
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. https://app.cochat.ai/papers/10.1002/jmri.22068
- The paper
- Ellingson, B. M., Malkin, M. G., Rand, S. D., Connelly, J. M., Quinsey, C., LaViolette, P. S., Bedekar, D. P., & Schmainda, K. M. (2010). Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.22068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.